Ledger.Open graph →
SEC Form D · Amendment · filed November 17, 2021

Variant Bio, Inc

Offering
$105.0M
Sold
$105.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Stuart Nagae · Seattle, WADirectorBob More · Seattle, WADirectorAndrew Farnum · Seattle, WAExec · DirectorStephane Castel · Seattle, WAExec · DirectorJulie Sunderland · Seattle, WADirectorElena Viboch · Seattle, WADirectorJosh Wolfe · Seattle, WADirectorCoby Lefkowitz · San Diego, CADirectorAnthony Choe · Beverly Hills, CADirectorLisheng Wang · Avon, CTDirectorGold Roee · San Diego, CAExec · DirectorGabriel Freifeld · San Diego, CADirectorTravis Jordan · Greenwich, CTExec · DirectorThomas H. Davis · Hamilton, BermudaDirectorKimball Carr · VIRGINIA BEACH, VADirectorPeter S. Lau · VIRGINIA BEACH, VADirectorCharles S. Keiser · VIRGINIA BEACH, VAExec · DirectorRichard S. Marten · Virginia Beach, VADirectorJames S. Coleman · Virginia Beach, VADirectorRichard Digirolamo · Natick, MAExec · DirectorMichael A. Hicklen · Birmingham, ALDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗